Jazz Pharmaceuticals plc Overview
Jazz Pharmaceuticals plc Target Price
Analysts' 12-month price predictions for JAZZ.
Share Price
$108.8
Average Target Price
$215.00
97.6% upside
97.6% upside2 analysts in the last 4 months
High: $230 | Low: $200
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-03-06 | Truist Financial | $230 | 111.4% upside |  |
| 2025-02-27 | BarclaysBalaji Prasad | $200 | 83.8% upside | |
| 2024-11-21 | JefferiesAkash Tewar | $160 | 47.1% upside | |
| 2024-11-18 | Robert W. BairdJoel Beatty | $162 | 48.9% upside | |
| 2024-10-23 | RBC CapitalDaniel Busb | $179 | 64.5% upside | |
| 2024-09-11 | Stifel NicolausAnnabel Samimy | $230 | 111.4% upside | |
| 2024-06-05 | Goldman SachsAndrea Tan | $169 | 55.3% upside | |
| 2024-05-02 | RBC CapitalDaniel Busb | $176 | 61.8% upside | |
| 2024-03-20 | Piper SandlerDavid Amsellem | $188 | 72.8% upside | |
| 2022-12-09 | Goldman Sachs | $190 | 74.6% upside | |
| 2022-11-10 | Goldman Sachs | $192 | 76.5% upside | |
| 2022-11-10 | RBC Capital | $207 | 90.3% upside | |
| 2022-06-20 | Piper SandlerDavid Amsellem | $193 | 77.4% upside | |
| 2022-06-13 | UBSAshwani Verma | $194 | 78.3% upside | |
| 2022-03-03 | NeedhamAmi Fadia | $215 | 97.6% upside | |
| 2022-01-20 | Truist FinancialGreg Fraser | $200 | 83.8% upside | |
| 2022-01-14 | Stifel NicolausAnnabel Samimy | $210 | 93% upside | |
| 2022-01-03 | BernsteinAaron Gal | $175 | 60.8% upside | |
| 2021-11-10 | Bank of America SecuritiesJason Gerberry | $193 | 77.4% upside | |
| 2021-10-06 | Cantor FitzgeraldBrandon Folkes | $210 | 93% upside | |
| 2021-10-05 | CitigroupNavann Ty | $200 | 83.8% upside | |
| 2021-06-22 | BarclaysBalaji Prasad | $250 | 129.8% upside | |
| 2021-06-18 | UBSEsther Rajavelu | $234 | 115.1% upside | |
| 2021-05-10 | Cowen & Co.Ken Cacciatore | $200 | 83.8% upside | |